The results showed that NFE2L3 was expressed differently in different immune subtypes of 12 cancer types, including KIRC, COAD, BRCA, UCEC, STAD, SKCM, PRAD, PAAD, MESO, LUSC, LIHC, and LGG (Figure 7E). This evidence concerns the gene NFE2L3 and cancer.